WeChat Mini Program
Old Version Features

Sequential Therapy of Crizotinib Followed by Alectinib for Non-Small Cell Lung Cancer Harbouring Anaplastic Lymphoma Kinase Rearrangement (WJOG9516L): A Multicenter Retrospective Cohort Study

Kentaro Ito,Takeharu Yamanaka,Hidetoshi Hayashi,Yoshihiro Hattori,Kazumi Nishino,Haruki Kobayashi,Yuko Oya,Toshihide Yokoyama,Takashi Seto,Koichi Azuma,Tomoya Fukui,Toshiyuki Kozuki,Atsushi Nakamura,Kentaro Tanaka,Katsuya Hirano,Takashi Yokoi,Haruko Daga,Shinya Sakata,Daichi Fujimoto,Masahide Mori,Ken Maeno,Takuya Aoki,Atsuhisa Tamura,Satoru Miura,Satoshi Watanabe,Hiroaki Akamatsu,Osamu Hataji,Kensuke Suzuki,Shigeto Hontsu,Koji Azuma,Akihiro Bessho,Akihito Kubo,Motoyasu Okuno,Kazuhiko Nakagawa,Nobuyuki Yamamoto

European Journal of Cancer（2021）

Cited 21|Views85
Key words
Anaplastic lymphoma kinase,Non-small cell lung cancer,Crizotinib,Alectinib,Sequential therapy,Real-world data
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined